Emerging roles of prostanoids in T cell-mediated immunity

IUBMB Life

Volumn 62, Issue 8, 2010, Pages 591-596

  Sakata, Daiji ^a   Yao, Chengcan ^a   Narumiya, Shuh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Immune diseases; Knockout mice; Prostanoid; Prostanoid receptor; T cell subset

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MISOPROSTOL; PROSTANOID; PROSTANOID RECEPTOR;

ALLERGIC ASTHMA; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW; T LYMPHOCYTE; TH17 CELL;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; MICE; NEOPLASMS; PROSTAGLANDINS; T-LYMPHOCYTES;

MUS;

EID: 77955905556     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.356     Document Type: Review

References (33)

1. Zhu, J., and Paul, W. E. (2008) CD4 T cells: fates, functions, and faults. Blood. 112, 1557-1569.
2. Steinman, L. (2007) A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med., 13, 139-145.
3. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. (2009) IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517.
4. Narumiya, S. (2007) Physiology and pathophysiology of prostanpoid receptors. Proc. Japan Acad. Ser. B. 83, 296-319.
5. Goodwin, J. S., and Ceuppens, J. (1983) Regulation of the immune response by prostaglandins. J. Clin. Immunol. 3, 295-315.
6. Betz, M., and Fox, B. S. (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113.
7. Harris, S. G., Padilla, J., Koumas, L., Ray, D., and Phipps, R. P. (2002) Prostaglandins as modulators of immunity. Trends Immunol. 23, 144-150.
8. Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M. T., Mannon, R., Koller, B. H., and Coffman, T. M. (2001) Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229-1235.
9. Mustelin, T., and Tasken, K. (2003) Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371, 15-27.
10. Chemnitz, J. M., Driesen, J., Classen, S., Riley, J. L., Debey, S., Beyer, M., Popov, A., Zander, T., and Schultze, J. L. (2006) Prostaglandin E2 impairs CD41 T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66, 1114-1122.
11. Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto, Y., and Narumiya, S. (2009) Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Nat. Med. 15, 633-640.
12. Chen, H., Qin, J., Wei, P., Zhang, J., Li, Q., Fu, L, Li, S., Ma, C., and Cong, B. (2009) Effect of leukotoriene B4 and prostaglandin E2 on the differentiation of murine Foxp31 T regulatory cells and Th17 cells. Prostaglandin Leukot. Essent. Fatty Acids 80, 195-200.
13. Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., and de Waal Malefyt, R. (2009) Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535-548.
14. Chizzolini, C., Chicheportichem, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., and Dayer, J. M. (2008) Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112, 3696-3703.
15. Napolitani, G., Acosta-Rodriguez, E. V., Lanzavecchia, A., and Sallusto, F. (2009) Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD41 T cells. Eur. J. Immunol. 39, 1301-1312.
16. Sheibanie, A. F., Tadmori, I., Jing, H., Vassiliou, E., and Ganea, D. (2004) Prostaglandin E2 induces IL-23 production in bone marrowderived dendritic cells. FASEB J. 18, 1318-1320.
17. Khayrullina, T., Yen, J. H., Jing, H., and Ganea, D. (2008) In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 181, 721-735.
18. Sheibanie, A. F., Khayrullina, T., Safadi, F. F., and Ganea, D. (2007) Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Aethritis Rheum. 56, 2608-2619.
19. Sheibanie, A. F., Yen, J. H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., and Ganea, D. (2007) The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-[IL-17 axis. J. Immunol. 178, 8138-8147.
20. Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., Ichikawa, A., and Narumiya, S. (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883-893
21. Nagamachi, M., Sakata, D., Kabashima, K., Furuyashiki, T., Murata, T., Segi-Nishida, E., Soontrapa, K., Matsuoka, T., Miyachi, Y., and Narumiya, S. (2007) Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J. Exp. Med. 204, 2865-2874.
22. Kihara, Y., Matsushita, T., Kita, Y., Uematsu, S., Arira, S., Kira, J., Ishii, S., and Shimizu, T. (2009) Targeted lipidomics reveals mPGES-1-PGE2 as atherapeutic target for multiple sclerosis, Proc. Natl. Acad. Sci. USA 106, 21807-21812.
23. Nakajima, S., Honda, T., Sakata, D., Egawa, G., Tanizaki, H., Otsuka, A., Moniaga, C. S., Watanabe, T., Miyachi, Y., Narumiya, S., and Kabashima, K. (2010) Prostaglandin I2 signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J. Immunol. 184, 5595-5603.
24. Moriyama, T., Higashi, T., Togashi, K., Iida, T., Segi, E., Sugimoto, Y., Tominaga, T., Narumiya, S., and Tominaga, M. (2005) Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain 1, 1-13
25. Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., Eguchi, N., Urade, Y., Yoshida, N., Kimura, K., Mizoguchi, A., Honda, Y., Nagai, H., and Narumiya, S. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science 287, 2013-2019.
26. Kunikata, T., Yamane, H., Segi, E., Matsuoka, T., Sugimoto, Y., Tanaka, S., Tanaka, H., Nagai, H., Ichikawa, A., and Narumiya, S. (2005) Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat. Immunol. 6, 524-531.
27. Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., Inagaki, N., Narumiya, S., and Nagai, H. (2002) Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137, 315-322.
28. Ushikubi, F., Aiba, Y., Nakamura, K., Namba, T., Hirata, M., Mazda, O., Katsura, Y., and Narumiya, S. (1993) Thromboxane A2 receptor Is highly aexpressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178, 1825-1830
29. Rocha, P. N., Plumb, T. J., Robinson, L. A., Spurney, R., Pisetsky, D., Koller, B. H., and Coffmen, T. M. (2005) Role of thromboxane A2 in the induction of apoptosis of immature thymocytes by lipopolysaccharide. Clin. Diagn. Lab. Immunol. 12, 896-903.
30. Kabashima, K., Murata, T., Tanaka, H., Matsuoka, T., Sakata, D., Yoshida, N., Katagiri, K., Kinashi, T., Tanaka, T., Miyasaka, M., Nagai, H., Ushikubi, F., and Narumiya, S. (2003) Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4, 694-701.
31. Xavier, R. J., and Podolsky, D. K. (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
32. Libioulle, C., Louis, E., Hansoul, S., Sandor C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., Demarche, B, Gut, I., Health, S., Foglio, M., Liang, L., Laukens, D., Mni, M., Zelenika, D., Van Gossum, A., Rutgeerts, P., Balaiche, J., Lathrop, M., and Georges, M. (2007) Novel Crohn disease locus identified by genomewide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS. Genet. 20, e58.
33. Oguma, T., Palmer, L. J., Birben, E., Sonna, L. A., Asano, K., and Lilly, C. M. (2004) Role of prostanoid DP receptor variants in susceptibility to asthma. N. Engl. J. Med. 351, 1752-1763.